| 1. |
Onodera M, Ariga T, Kawamura N, Kobayashi I, Ohtsu M, Yamada M, Tame A, Furuta H, Okano M, Matsumoto S, Kotani H, McGarrity
GJ, Blaese RM, Sakiyama Y. (1998) Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined
immune deficiency caused by adenosine deaminase deficiency. Blood. 91, 30Ð6
|
| |
| 2. |
Palù G, Pira GLi, Gennari F, Fenoglio D, Parolin C and Manca F. (2001) Genetically modified immunocompetent cells in HIV infection.
Gene Therapy. 21, 1593Ð1600
|
| |
| 3. |
Nakajima A. (2006) Application of cellular gene therapy for rheumatoid arthritis. Mod Rheumatol. 5, 269Ð275
|
| |
| 4. |
Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z,
Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, Rosenberg SA. (2006) Cancer regression in patients after transfer
of genetically engineered lymphocytes. Science. 314, 126Ð129
|
| |
| 5. |
Hwu P, Yannelli J, Kriegler M, Anderson WF, Perez C, Chiang Y, Schwarz S, Cowherd R, Delgado C, Mule J, Rosenberg SA. (1993)
Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA
for the gene therapy of cancer in humans. J Immunol. 150, 4104Ð4115
|
| |
| 6. |
Pear WS, Scott ML, Nolan GP. (1996) Gen-eration of high titre, helper-free retroviruses by transient transfection, in Robbins
PD (ed). Methods in Molecular Medicine: Gene Therapy Protocols. Humana, Totowa, NJ, pp 41Ð57
|
| |
| 7. |
Wang H, Kavanaugh MP, North RA, Kabat D. (1991) Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid
transporter. Nature. 352, 729Ð731
|
| |
| 8. |
Sadelain M. (1996) Methods for Retrovirus-Mediated Gene Transfer into Primary T-Lym-phocytes, in Robbins PD (ed). Methods
in Molecular Medicine: Gene Therapy Protocols. Humana, Totowa, NJ, pp 241Ð248
|
| |
| 9. |
Riviere I, Brose K, Mulligan RC. (1995) Effects of retroviral design on expression of human adenosine deaminase in murine
bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA. 92, 6733Ð6737
|
| |
| 10. |
Hagani AB, Riviere I, Tan C, Krause A, Sadelain M. (1999) Activation conditions determine susceptibility of murine primary
T-lymphocytes to retroviral infection. J Gene Med. 1, 341Ð351
|
| |
| 11. |
Pollok KE, Hanenberg H, Noblitt TW, Schroeder WL, Kato I, Emanuel D, Williams DA. (1998) High-efficiency gene transfer into
normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments. J Virol. 72, 4882Ð4892
|
| |
| 12. |
Brentjens RJ, Latouche JB, Santos E, Marti F, Gong MC, Lyddane C, King PD, Larson S, Weiss M, Riviere I, Sadelain M. (2003)
Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.
Nat Med. 9, 279Ð286
|
| |
| 13. |
Deane JA, Trifilo MJ, Yballe CM, Choi S, Lane TE, Fruman DA. (2004) Enhanced T cell proliferation in mice lacking the p85beta
subunit of phosphoinositide 3-kinase. J Immunol. 172, 6615Ð6625
|
| |
| 14. |
Coligan JE, Kruisbeer AM, Marguilies DH, Shevach EM, and Strober W. (1993) T cell enrichment by nonadherence to nylon, in
Current Protocols in Immunology. Wiley, NY, pp 3.2.1
|
| |
| 15. |
Loyter A, Scangos GA, Ruddle FH. (1982) Mechanisms of DNA uptake by mammalian cells: fate of exogenously added DNA monitored
by the use of fluorescent dyes. Proc Natl Acad Sci USA. 79, 422Ð426
|
| |